Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Barth

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Mabs|July 29, 2015
Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsiesDmitrij Hristodorov, Radoslav Mladenov, Verena von Felbert, et al.
Biomedicines|September 13, 2017
CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory DiseasesOlusiji A Akinrinmade, Shivan Chetty, Adebukola K Daramola, et al.
Biomedicines|June 28, 2017
Human MAP Tau Based Targeted Cytolytic Fusion ProteinsOlusiji A Akinrinmade, Sandra Jordaan, Dmitrij Hristodorov, et al.
Biomedicines|June 29, 2017
CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAILSandra Jordaan, Shivan Chetty, Neelakshi Mungra, et al.
Mabs|March 12, 2015
Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemiaJenny Fitting, Tobias Blume, Andre Ten Haaf, et al.
Cancer Medicine|May 6, 2025
SNAP-Tag-Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light-Accessible Melanotransferrin-Expressing Melanoma and Triple-Negative Breast CancerSuzanne Hippolite Magagoum, Fleury Augustin Nsole Biteghe, Gael Tchokomeni Siwe, et al.
Microorganisms|December 23, 2023
AAV Immunotoxicity: Implications in Anti-HBV Gene TherapyRidhwaanah Jacobs, Makafui Dennis Dogbey, Njabulo Mnyandu, et al.
Bioconjugate Chemistry|October 15, 2011
SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cellsAhmad Fawzi Hussain, Florian Kampmeier, Verena von Felbert, et al.
Journal of Cancer Research and Clinical Oncology|July 3, 2017
Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16]Elena Grieger, Gerrit Gresch, Judith Niesen, et al.
International Journal of Cancer|April 20, 2004
Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cellsClaudia Heuser, Stefan Guhlke, Alexander Matthies, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Mabs|July 29, 2015
Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsiesDmitrij Hristodorov, Radoslav Mladenov, Verena von Felbert, et al.
Biomedicines|September 13, 2017
CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory DiseasesOlusiji A Akinrinmade, Shivan Chetty, Adebukola K Daramola, et al.
Biomedicines|June 28, 2017
Human MAP Tau Based Targeted Cytolytic Fusion ProteinsOlusiji A Akinrinmade, Sandra Jordaan, Dmitrij Hristodorov, et al.
Biomedicines|June 29, 2017
CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAILSandra Jordaan, Shivan Chetty, Neelakshi Mungra, et al.
Mabs|March 12, 2015
Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemiaJenny Fitting, Tobias Blume, Andre Ten Haaf, et al.
Cancer Medicine|May 6, 2025
SNAP-Tag-Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light-Accessible Melanotransferrin-Expressing Melanoma and Triple-Negative Breast CancerSuzanne Hippolite Magagoum, Fleury Augustin Nsole Biteghe, Gael Tchokomeni Siwe, et al.
Microorganisms|December 23, 2023
AAV Immunotoxicity: Implications in Anti-HBV Gene TherapyRidhwaanah Jacobs, Makafui Dennis Dogbey, Njabulo Mnyandu, et al.
Bioconjugate Chemistry|October 15, 2011
SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cellsAhmad Fawzi Hussain, Florian Kampmeier, Verena von Felbert, et al.
Journal of Cancer Research and Clinical Oncology|July 3, 2017
Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16]Elena Grieger, Gerrit Gresch, Judith Niesen, et al.
International Journal of Cancer|April 20, 2004
Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cellsClaudia Heuser, Stefan Guhlke, Alexander Matthies, et al.
Pageof 15